IOVA vs GILD: Which Stock is Better?
Side-by-side comparison of Iovance Biotherapeutics Inc and Gilead Sciences Inc in 2026
IOVA
Iovance Biotherapeutics Inc
$3.64
GILD
Gilead Sciences Inc
$140.45
Key Metrics Comparison
| Metric | IOVA | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.43B | $172.56B | GILD |
| P/E Ratio | N/A | 20.51 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.2% | 0.0% | IOVA |
| Gross Margin | 34.3% | 78.8% | GILD |
Analyze IOVA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IOVA or GILD a better investment?
Comparing IOVA and GILD: Iovance Biotherapeutics Inc has a market cap of $1.43B while Gilead Sciences Inc has $172.56B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IOVA and GILD?
IOVA (Iovance Biotherapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IOVA or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IOVA or GILD?
IOVA has higher revenue growth at 0.2% vs 0.0% for GILD.
Which company is more profitable: IOVA or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 34.3% for IOVA.
Which is the larger company: IOVA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $172.56B compared to $1.43B for IOVA.
Should I buy IOVA or GILD in 2026?
Both IOVA and GILD have investment merit. IOVA trades at $3.64 while GILD trades at $140.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IOVA and GILD stock?
Key differences: Market Cap ($1.43B vs $172.56B), P/E Ratio (N/A vs 20.5x), Revenue Growth (0.2% vs 0.0%), Gross Margin (34.3% vs 78.8%).